Day One Biopharmaceuticals Overview

Day One Biopharmaceuticals Total Revenue

Revenue analysis for DAWN.

Quarterly Revenue

$53.72M

↑ 83.92% YoY

As of Dec 2025

Annual Revenue (TTM)

$158.18M

↑ 175.24% YoY

Trailing 12 months ending Dec 2025

Average Revenue (Comparison Companies)

Total Revenue History

Total Revenue Comparison

Annual Revenue Growth Rate (%)

Annual Revenue Growth (Absolute)

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin